What is the treatment dose for Albuterol (Salbutamol) nebulizer (nebulized) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The standard dose of albuterol nebulizer treatment for adults is 2.5–5 mg every 20 minutes for 3 doses, then 2.5–10 mg every 1–4 hours as needed, while for children, the dose is 0.15 mg/kg (minimum dose 2.5 mg) every 20 minutes for 3 doses, then 0.15–0.3 mg/kg up to 10 mg every 1–4 hours as needed, as recommended by the National Asthma Education and Prevention Program expert panel report 3 guidelines for the management of asthma exacerbations 1.

Key Considerations

  • The medication should be diluted with normal saline to a total volume of 3 mL at a gas flow of 6–8 L/min for optimal delivery.
  • Large volume nebulizers should be used for continuous administration.
  • Albuterol can be mixed with ipratropium nebulizer solution.
  • Potential side effects include tremor, tachycardia, and nervousness.

Administration

  • Patients should be seated upright and instructed to breathe normally through the mouthpiece until the solution is completely nebulized, which typically takes 5-10 minutes.
  • The onset of action is typically within 5-15 minutes, with effects lasting 4-6 hours.

Evidence-Based Recommendations

  • The National Asthma Education and Prevention Program expert panel report 3 guidelines for the management of asthma exacerbations provide the most recent and highest quality evidence for albuterol nebulizer treatment dosing 1.
  • The guidelines recommend selective beta2-agonists, such as albuterol, for the treatment of asthma exacerbations.
  • The guidelines also provide recommendations for the use of ipratropium bromide in combination with albuterol for severe exacerbations.

From the FDA Drug Label

Patient Package Insert Albuterol Sulfate Inhalation Solution, 0.083%* 2.5 mg*/3 mL *Potency expressed as albuterol, equivalent to 3 mg albuterol sulfate. Note: This is a unit-dose vial. No dilution is required. INSTRUCTIONS FOR USE Remove vial from the foil pouch. Twist the cap completely off the vial and squeeze the contents into the nebulizer reservoir More frequent administration or higher doses are not recommended.

The recommended dose for albuterol neb treatment is 2.5 mg (equivalent to 3 mg albuterol sulfate) per treatment, administered as needed 2.

From the Research

Albuterol Neb Treatment Dose

  • The optimal dose of albuterol for neb treatment is not well established, with different studies suggesting various dosages 3, 4, 5, 6, 7.
  • A study from 1995 compared high-dose continuous nebulization of albuterol (7.5 mg/h) to high-dose intermittent nebulization of albuterol (2.5 mg every 20 minutes) and found that both regimens were safe and efficacious in the early treatment of asthma in an emergency department 3.
  • Another study from 2020 compared two continuous nebulized albuterol doses (10 vs. 25 mg/h) in critically ill children with status asthmaticus and found that the lower dose was associated with lower fluid bolus resuscitation without increased adjunctive therapies 4.
  • A 2021 study examined the association of various weight-based doses of continuous albuterol on hospital length of stay and found no difference in adjusted length of stay or adjusted duration of continuous albuterol therapy among the five quintiles of weight-based dosage 5.
  • A 1993 study tested the efficacy and safety of a continuous albuterol protocol for the treatment of acute adult asthma attacks and found that patients showed statistically significant increases in peak flow and statistically significant decreases in respiratory rate, pulse, and clinical severity 6.
  • A 2006 study compared the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma and found no statistically significant difference in improvement of mean PEFR at 60 or 120 min between groups 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1995

Research

Comparison of two continuous nebulized albuterol doses in critically ill children with status asthmaticus.

The Journal of asthma : official journal of the Association for the Care of Asthma, 2020

Research

Association of various weight-based doses of continuous albuterol on hospital length of stay.

The Journal of asthma : official journal of the Association for the Care of Asthma, 2021

Related Questions

What is the best initial treatment for a patient with asthma exacerbation and tachycardia, specifically regarding nebulizer (nebs) therapy?
What is the recommended duration of a nebulizer treatment with a bronchodilator such as albuterol (beta2-adrenergic agonist) during an asthma attack?
What is the recommended dosage of albuterol (beta-2 adrenergic receptor agonist) for continuous nebulization in pediatric asthma inpatients?
What is the recommended dosage of continuous albuterol (salbutamol) treatment for pediatric patients?
What are the guidelines for continuous albuterol (beta2-adrenergic agonist) therapy in pediatric patients?
What is the best Angiotensin-Converting Enzyme (ACE) inhibitor or Angiotensin Receptor Blocker (ARB) for treating microalbuminuria?
How do non-stimulating Antidiuretic Hormone (ADH) medications work?
What are the symptoms and laboratory findings that distinguish vulvovaginal candidiasis (VVC) from bacterial vaginosis (BV)?
Does a left bundle branch block (LBBB) cause a prolonged QTc interval (corrected QT interval)?
What is the appropriate management for a 52-year-old patient with a history of Non-ST-Elevation Myocardial Infarction (NSTEMI), atrial fibrillation with rapid ventricular response, impaired left ventricular function (Left Ventricular Ejection Fraction (LVEF) 45%), acute kidney injury, urinary tract infection, and suicidal ideation, currently on dual antiplatelet therapy with aspirin and Eliquis (apobarin) and metoprolol, with decreased vision and no recent follow-up with cardiology or ophthalmology?
Is Irenka (Duloxetine) equivalent to Cymbalta (Duloxetine)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.